Drug patents …
… from Kazakhstan to Kalamazoo

Manage your pharmacy inventory

Project your formulary budget

Find generic entry opportunities

Anticipate generic drug launch

Deep knowledge on
small-molecule drugs and
the global patents
covering them

Deeper Knowledge, Faster

Analyze global market entry opportunities
Identify first generic entrants
Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Generated: September 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077470

« Back to Dashboard

NDA 077470 describes RAMIPRIL, which is a drug marketed by West-ward Pharms Int, Aurobindo Pharma Ltd, Cipla, Actavis Elizabeth, Sandoz, Apotex, Lupin, Zydus Pharms Usa, Invagen Pharms, Ranbaxy Labs Ltd, Watson Labs, Mylan Pharms Inc, Apotex Inc, Teva Pharms, Dr Reddys Labs Ltd, Accord Hlthcare, and Zydus Pharms Usa Inc, and is included in seventeen NDAs. It is available from thirty-four suppliers. Additional details are available on the RAMIPRIL profile page.

The generic ingredient in RAMIPRIL is ramipril. There are nineteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the ramipril profile page.

Summary for NDA: 077470

Tradename:	1
Applicant:	1
Ingredient:	1
Patents:	0
Therapeutic Class:	Cardiovascular Agents
Formulation / Manufacturing:	see details

Pharmacology for NDA: 077470

Mechanism of Action	Angiotensin-converting Enzyme Inhibitors

Suppliers and Packaging for NDA: 077470

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
RAMIPRIL	ramipril	CAPSULE;ORAL	077470	ANDA	Lake Erie Medical DBA Quality Care Products LLC	35356-893	35356-893-30	30 CAPSULE in 1 BOTTLE (35356-893-30)
RAMIPRIL	ramipril	CAPSULE;ORAL	077470	ANDA	Lake Erie Medical DBA Quality Care Products LLC	35356-893	35356-893-60	60 CAPSULE in 1 BOTTLE (35356-893-60)

Summary for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	1.25MG
Approval Date:	Jun 18, 2008	TE:	AB	RLD:	No

Summary for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	2.5MG
Approval Date:	Jun 18, 2008	TE:	AB	RLD:	No

Summary for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	5MG
Approval Date:	Jun 18, 2008	TE:	AB	RLD:	No

Complete Access Available with Subscription

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.